We are live on
!
Find out more
MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
13 hedge funds and large institutions have $3.62M invested in Stealth BioTherapeutics Corp. ADS in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
148% more capital invested
Capital invested by funds: $1.46M → $3.62M (+$2.16M)
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.29M |
| 2 |
Renaissance Technologies
New York
|
+$538K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$518K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$161K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$135K |
